Table 3.
Treatment and prognosis of patients in retrospective section.
| N (%) | Treatment | Prognosis | ||||||
|---|---|---|---|---|---|---|---|---|
| WLL | Nebulization of GM-CSF | Subcutaneous of GM-CSF | Symptomatic and other treatment | Improvement | Stable | Deterioration | ||
| DSS | ||||||||
| Mild | 143 (61.9) | 21 | 24 (WLL: 8)a | 28 (WLL: 2) | 69 | 56 | 56 | 31 |
| Moderate | 60 (26.0) | 11 | 12 (WLL: 2) | 13 (WLL: 1) | 26 | 27 | 19 | 14 |
| Severe | 28 (12.1) | 9 | 2 (WLL: 1) | 6 (WLL: 2) | 8 | 13 | 9 | 6 |
| SPSP | ||||||||
| Mild | 47 (20.3) | 4 | 5 (WLL: 1) | 2 | 36 | 17 | 22 | 8 |
| Moderate | 91 (39.4) | 8 | 13 (WLL: 2) | 25 (WLL: 2) | 45 | 43 | 35 | 13 |
| Severe | 93 (40.3) | 29 | 20 (WLL: 8) | 30 (WLL: 3) | 10 | 36 | 27 | 30 |
| SPSPII | ||||||||
| Mild | 48 (20.8) | 4 | 4 (WLL: 1) | 4 | 36 | 18 | 21 | 9 |
| Moderate | 88 (38.1) | 11 | 13 (WLL: 3) | 27(WLL: 2) | 39 | 41 | 34 | 13 |
| Severe | 95 (41.1) | 26 | 21 (WLL: 7) | 16 (WLL: 3) | 38 | 37 | 29 | 29 |
DSS, Disease severity score; GM-CSF, Granulocyte-macrophage colony-stimulating factor; WLL, Whole lung lavage.
a
The patients had the history of whole lung lavage.